Deciphering the prognostic role of endoplasmic reticulum stress in lung adenocarcinoma: integrating prognostic prediction and immunotherapy strategies
Clinical and Experimental Medicine · 2024
DOI: 10.1007/s10238-024-01439-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Bing Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Endoplasmic Reticulum Stress, Lung Neoplasms, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Tianjin Municipality.
Abstract (Originalsprache)
Endoplasmic reticulum stress (ERS) is a critical factor influencing lung adenocarcinoma (LUAD) progression and patient outcomes. In this study, we analyzed gene expression data from LUAD samples sourced from The Cancer Genomic Atlas and Gene Expression Omnibus databases. Utilizing advanced statistical methods including LASSO and Cox regression, we developed a ERS-associated signature (ERAS) based on ten ERS-related genes. This model stratified patients into high- and low-risk groups, with the high-risk group exhibiting decreased survival rates, elevated tumor mutational burden, and heightened chemotherapy sensitivity. Additionally, we observed lower immune and ESTIMATE scores in the high-ERAS group, indicating a potentially compromised immune response. Experimental validation through quantitative real-time polymerase chain reaction confirmed the utility of our model. Furthermore, we constructed a nomogram to predict 1-, 3-, and 5-year survival rates, providing clinicians with a valuable tool for personalized patient management. In conclusion, our study demonstrates the efficacy of the ERAS in identifying high-ERAS LUAD patients, offering promising implications for improved prognostication and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical Univer…
- Department of Cardiothoracic Surgery, The Second People's Hospital of Yibin, Yibin, Sichuan, China.
- Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Förderung
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Wen, B., Zhang, P., Xie, J., Zhou, Z., Zhang, G., Zhang, L., & Zhang, Z. (2024). Deciphering the prognostic role of endoplasmic reticulum stress in lung adenocarcinoma: integrating prognostic prediction and immunotherapy strategies. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01439-4
Vancouver
Wen B, Zhang P, Xie J, Zhou Z, Zhang G, Zhang L, et al. Deciphering the prognostic role of endoplasmic reticulum stress in lung adenocarcinoma: integrating prognostic prediction and immunotherapy strategies. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01439-4
BibTeX
@article{Wen2024,
author = {Wen, Bing and Zhang, Pengpeng and Xie, Jiping and Zhou, Zhaokai and Zhang, Ge and Zhang, Lianmin and Zhang, Zhenfa},
title = {Deciphering the prognostic role of endoplasmic reticulum stress in lung adenocarcinoma: integrating prognostic prediction and immunotherapy strategies},
journal = {Clinical and Experimental Medicine},
year = {2024},
doi = {10.1007/s10238-024-01439-4}
}
EUVIMED